##semicolon##
острый ишемический инсульт, эндоваскулярная реканализация, механическая тромбэктомия, тромбаспирация, стент-ретривер, терапевтическое окно, коллатерали.##submission.citations##
Albers G.W., Marks M.P., Kemp S. et al. DEFUSE 3 Investigators. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging // New Engl. J. Med. – 2018. – Vol. 378, №8. – Р. 708-718. doi: 10.1056/ NEJMoa1713973.
Azhieva Z.B. Dynamics and prognosis of the incidence of cerebral strokes, according to registry of Nukus city // Neurology (Uzbekistan). – 2008. – №3-4. – 44 p. (In Russian).
Berkhemer O.A., Fransen P.S., Beumer D. et al. MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke // New Engl. J. Med. – 2015. – Vol. 372, №1. – Р. 11-20. doi: 10.1056/NEJMoa1411587.
Broderick J.P., Palesch Y.Y., Demchuk A.M. et al. IMS III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke // New Engl. J. Med. – 2013. – Vol. 368. – Р. 893-903.
Campbell B.C., Mitchell P.J., Kleinig T.J. et al. EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection // New Engl. J. Med. – 2015. – Vol. 372, 11. – Р. 1009-1018. doi: 10.1056/NEJMoa1414792.
Campbell B.C.V., Oxley T.J., Chapot R. Acute ischemic stroke. Time, penumbra, and reperfusion // Stroke. – 2014. – Vol. 45. – Р. 640-644.
Ciccone A., Valvassori L., Nichelatti M. et al. SYNTHESIS Expansion Investigators. Endovascular treatment for acute ischemic stroke // New Engl. J. Med. – 2013. – Vol. 368. – Р. 904-913.
Del Zoppo G.J., Higashida R.T., Furlan A.J. et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators (Prolyse in Acute Cerebral Thromboembolism) // Stroke. – 1998. – Vol. 29. – Р. 4-11.
Drumm B., Banerjee S., Qureshi M.M. et al. Current opinions on optimal management of basilar artery occlusion: after the BEST of BASICS survey // Stroke: Vasc. Intervent. Neurol. – 2022. – Vol. 2. – Р. e000538.
Feigin V.L. et al. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016 // New Engl. J. Med. – 2018. – Vol. 379 (25). – Р. 2429-2437.
Feigin V.L. et al. Update on the global burden of ischemic and hemorrhagic stroke in 1990–2013: the GBD 2013 study // Neuroepidemiology. – 2015. – Vol. 45, №3. – Р. 161-176.
Gafurov B.G. The rate and clinical structure of cerebral strokes in Uzbekistan based on hospital registry // Proceedings of the Scientific Conference “Relevant problems in Surgery”. – Tashkent, 2009. (In Russian).
Global Burden of Disease Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017 // Lancet. – 2018. – Vol. 392. – Р. 1736-1788.
Global Burden of Disease Stroke Collaborators. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 // Lancet Neurol. – 2019. – Vol. 18, №5. – Р. 439-458.
Gobin Y.P., Starkman S., Duckwiler G.R. et al. MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia // Stroke. – 2004. – Vol. 35. – Р. 2848-2854.
Goyal M., Demchuk A.M., Menon B.K. et al. ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke // New Engl. J. Med. – 2015. – Vol. 372, №11. – Р. 1019-1030. doi: 10.1056/NEJMoa1414905.
Jovin T.G., Liebeskind D.S., Gupta R. et al. Imaging-based endovascular therapy for acute ischemic stroke due to proximal intracranial anterior circulation occlusion treated beyond 8 hours from last seen well: a retrospective multicenter analysis of 237 consecutive patients // Stroke. – 2011. – Vol. 42, №8. – Р. 2206-2211. doi: 10.1161/STROKEAHA. 110.604223.
Jovin T.G., Chamorro A., Cobo E. et al. REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke // New Engl. J. Med. – 2015. – Vol. 372. – Р. 2296-2306.
Jovin T.G., Li C., Wu L. et al. Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion // New Engl. J. Med. – 2022. – Vol. 387. – Р. 1373-1384.
Kidwell C.S., Jahan R., Gornbein J. et al. MR RESCUE Investigators. A trial of imaging selection and endovascular treatment for ischemic stroke // New Engl. J. Med. – 2013. – Vol. 368. – Р. 914-923.
Kühn A.L., Vardar Z., Kraitem A., King R.M. et al. Biomechanics and hemodynamics of stent-retrievers // J. Cereb. Blood Flow Metab. – 2020. – Vol. 40, №12. – Р. 2350-2365. doi: 10.1177/0271678X20916002.
Langezaal L.C.M., van der Hoeven E.J.R.J., Mont’Alverne F.J.A. et al. Endovascular therapy for stroke due to basilar-artery occlusion // New Engl. J. Med. – 2021. – Vol. 384. – 1910-1920.
Levy E.I., Siddiqui A.H., Crumlish A. First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (Stent-Assisted Recanalization in Acute Ischemic Stroke) // Stroke. – 2009. – Vol. 40, №11. – Р. 3552-3556. doi: 10.1161/STROKEAHA.109.561274.
Levy E.I., Ecker R.D., Horowitz M.B. et al. Stent-assisted intracranial recanalization for acute stroke: early results // Neurosurgery. – 2006. – Vol. 58. – Р. 458-463 (discussion 458-463).
Li C., Wu C., Wu L. et al. Basilar Artery Occlusion Chinese Endovascular Trial (BAOCHE) // European Stroke Organisation Conference, 2022.
Lindsberg P.J., Pekkola J., Strbian D., Sairanen T., Mattle H.P., Schroth G. Time window for recanalization in basilar artery occlusion: speculative synthesis // Neurology. – 2015. – Vol. 85. – Р. 1806-1815.
Liu X., Dai Q., Ye R. et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial // ancet Neurol. – 2020. – Vol. 19. – Р. 115-122.
Mahon B.R., Nesbit G.M., Barnwell S.L. et al. North American clinical experience with the EKOS MicroLysUS infusion catheter for the treatment of embolic stroke // Amer. J. Neuroradiol. 2003. – Vol. 24. – Р. 534-538.
Nakano S., Iseda T., Yoneyama T. et al. Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: an alternative option to intraarterial thrombolysis // Stroke. – 2002. – Vol. 33. – Р. 2872-2876.
Nogueira R.G., Jadhav A.P., Haussen D.C. et al. DAWN Trial Investigators. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct // New Engl. J. Med. – 2018. – Vol. 378, №1. – P. 11-21. doi: 10.1056/NEJMoa1706442.
Parsons M.W., Albers G.W. MR RESCUE: is the glass half-full or half-empty? Stroke. – 2013. – Vol. 44. – Р. 2055-2057.
Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease // Stroke. – 2009. – Vol. 40, №8. – Р. 2761-2768. doi: 10.1161/STROKEAHA.108.544957.
Powers W.J., Rabinstein A.A., Ackerson T. et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke – a guideline for healthcare professionals from the American Heart Association/American Stroke Association // Stroke. – 2019. – Vol. 50, №12. – Р. e344-e418. doi: 10.1161/STR.0000 000000000211.
Puig J., Shankar J., Liebeskind D. et al. From “time is brain” to “imaging is brain”: a paradigm shift in the management of acute ischemic stroke // J. Neuroimag. – 2020. – Vol. 30, №5. – Р. 562-571. doi: 10.1111/jon.12693.
Rasulova H.A. Risk factors in different stroke subtypes (Tashkent hospital-based study) // Vestnik TMA. – 2013. – №3. – Р. 120-128.
Rasulova Kh.A. Preliminary findings of Tashkent hospital-based study of risk factors for different ischemic stroke subtypes // Europ. Med. Health Pharmac. J. – 2014. – Vol. 7, №2. – Р. 26-33.
Sagatov D., Rasulova K., Madjidova Y. Risk factors and prognosis of ischemic stroke in young patients in Uzbekistan // Med. Health Sci. J. – 2011. – Vol. 5. – Р. 16-22.
Saver J.L., Goyal M., Bonafe A. et al. SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke // New Engl. J. Med. – 2015. – Vol. 372, 24. – Р. 2285-2295. doi: 10.1056/NEJMoa1415061.
Saver J.L., Jahan R., Levy E.I. et al. SWIFT Trialists. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial // Lancet. – 2012. – Vol. 380 (9849). – Р. 1241-1249. doi: 10.1016/S0140-6736(12)61384-1.
Saver J.L., Goyal M., Bonafe A. et al. SWIFT PRIME Investigators. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke // Intern. J. Stroke. – 2015. – Vol. 10. – Р. 439-448.
Schonewille W.J., Wijman C.A., Michel P. et al. Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study // Lancet Neurol. – 2009. – Vol. 8. – Р. 724-730.
Smith W.S., Sung G., Saver J. et al // Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial // Stroke. – 2008. – Vol. 39. – Р. 1205-1212.
Smith W.S., Sung G., Starkman S.Р. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial // Stroke. – 2005. – Vol. 36. – Р. 1432-1438.
Tao C., Li R., Zhu Y. et al. Endovascular treatment for acute basilar artery occlusion: a multicenter randomized clinical trial (ATTENTION) // European Stroke Organisation Conference, 2022.
Tirschwell D. Intra-arterial prourokinase for acute ischemic stroke. J.A.M.A. 2000; 283 (16): 2103 (author reply 2103-2104). Comment on: Furlan A., Higashida R., Wechsler L., Gent M., Rowley H., Kase C., Pessin M., Ahuja A., Callahan F., Clark W.M., Silver F., Rivera F. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial (Prolyse in Acute Cerebral Thromboembolism) // J.A.M.A. – 1999. – Vol. 282, №21. – Р. 2003-2011. doi: 10.1001/jama.282.21.2003.
Turc G., Bhogal P., Fischer U. et al. European Stroke Organisation (ESO) – European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischaemic Stroke. Endorsed by Stroke Alliance for Europe (SAFE) // Europ. Stroke J. – 2019. – Vol. 4, №1. – Р. 6-12. doi: 10.1177/2396987319832140.